New study aims to protect pregnant women with HIV from tuberculosis
NCT ID NCT07278453
First seen Jan 05, 2026 · Last updated May 10, 2026 · Updated 25 times
Summary
This study will enroll 1,500 pregnant women with HIV in Uganda to find the best way to screen for tuberculosis (TB) and the safest time to start TB prevention medicine. Researchers will compare symptom-based screening versus a blood test, and test starting prevention during pregnancy versus after birth. The goal is to reduce complications like miscarriage, stillbirth, and low birth weight, and improve long-term health for mothers and babies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS (TB) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kampala Capital City Authority (KCCA) clinics
Kampala, Uganda
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.